biochar
Commented by Fabian Lorenz on February 4th, 2026 | 08:50 CET
Yesterday +10%! Top news drives shares of Evotec, Novo Nordisk, and CHAR Technologies!
Evotec shares jumped, climbing more than 10% as analysts pushed the stock higher. Does this signal that the turnaround is finally happening, or does Deutsche Bank still have the final say? Strong news also for CHAR Technologies: the Canadian company is launching commercialization of its unique technology for producing biochar and renewable natural gas substitutes from biogenic waste materials. For the expansion, it has secured strong partners, including steel giant ArcelorMittal and the Canadian BMI Group. And what is Novo Nordisk doing? The Danish company presented positive study results for its successor to Wegovy. However, analysts are not exactly thrilled.
Read
Commented by Nico Popp on January 15th, 2026 | 07:25 CET
Double returns: How CHAR Technologies is closing the gap between ArcelorMittal's coal hunger and Montauk's gas profits
We are witnessing a historic turning point for global heavy industry. We are currently seeing not only a technological evolution, but also a fundamental revaluation of industrial assets, driven by two parallel megatrends: the decarbonization of primary steel production and the monetary revaluation of waste streams for energy security. While regulatory constraints are forcing steel giants such as ArcelorMittal to reinvent their blast furnaces, and specialists such as Montauk Renewables are demonstrating the enormous valuations possible in the renewable natural gas (RNG) market, CHAR Technologies is positioning itself at the intersection of these two worlds. With its proprietary high-temperature pyrolysis technology, the Canadian company provides the answer to both questions at once: it produces biochar for the steel industry and RNG for the energy grid – from a single waste source.
Read